These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8684517)

  • 1. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
    Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
    Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
    Goldwasser P; Michel MA; Collier J; Mittman N; Fein PA; Gusik SA; Avram MM
    Am J Kidney Dis; 1993 Jul; 22(1):215-25. PubMed ID: 8322786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma fibrinogen concentration with vascular access failure in hemodialysis patients.
    Song IS; Yang WS; Kim SB; Lee JH; Kwon TW; Park JS
    Nephrol Dial Transplant; 1999 Jan; 14(1):137-41. PubMed ID: 10052493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
    Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
    Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) in patients on hemodialysis.
    Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
    Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
    Levine DM; Gordon BR
    Am J Kidney Dis; 1995 Jul; 26(1):162-9. PubMed ID: 7611248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of vascular access occlusion in hemodialysis.
    Goldwasser P; Avram MM; Collier JT; Michel MA; Gusik SA; Mittman N
    Am J Kidney Dis; 1994 Nov; 24(5):785-94. PubMed ID: 7977320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis.
    Thillet J; Faucher C; Issad B; Allouache M; Chapman J; Jacobs C
    Am J Kidney Dis; 1993 Jul; 22(1):226-32. PubMed ID: 8322787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
    Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein (a) is a risk factor for cerebrovascular accident in patients with chronic renal failure].
    Ishikawa H
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):846-52. PubMed ID: 8072223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G; Buoncristiani U; Fagugli R; Kuluiranu H; Ciao G; Rondini L; Lowenthal DT; Reboldi G
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients.
    Ifudu O; Mayers JD; Cohen LS; Paul H; Brezsnyak WF; Avram MM; Herman AI; Friedman EA
    Am J Nephrol; 1996; 16(2):118-23. PubMed ID: 8919227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early elevation of lipoprotein(a) levels in chronic renal insufficiency.
    De Lima JJ; Maranhão RC; Latrilha Mda C; Diament J; Romão JE; Krieger EM; Pileggi F
    Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.
    Koda Y; Nishi S; Suzuki M; Hirasawa Y
    Kidney Int Suppl; 1999 Jul; 71():S251-3. PubMed ID: 10412791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.